Chief Scientific Officer
DEC Healthcare
Nick Gaddum obtained a BE(Hons) in Mechanical Engineering from Canterbury in 2004, and a PhD in Medical Engineering in Brisbane, Australia, in 2009. There he developed novel artificial heart technology, focusing on pump design and physiological controllers to respond to physical activity.
Moving to London, he established new MRI and ultrasound-based strategies to measure arterial disease to better diagnose Hypertension. He then took on the Lead Scientist role at Cell and Gene Therapy Catapult, working with start-up bio-pharmaceutical companies. This involved developing scalable, cost-driven manufacturing processes for novel cell-based therapies. Finally, as Director of Waiflow Ltd., he provided contract technical and IP support for medical device companies.
Returned to New Zealand in 2019, he took up the CSO role at DEC International NZ Ltd. establishing an R&D program to expand their medical devices portfolio. This role will drive both proprietary technology development, as well as collaborative and contract manufacturing projects.
Monday, July 24, 2023
5:00 PM – 7:00 PM US PST
